NCT02052648 2024-03-27Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain TumorsLumos PharmaPhase 1/2 Completed160 enrolled 21 charts
NCT02502708 2020-06-04Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain TumorsLumos PharmaPhase 1 Completed81 enrolled